CymaBay Therapeutics Inc (NASDAQ:CBAY)

3.41
Delayed Data
As of May 29
 -0.09 / -2.57%
Today’s Change
2.67
Today|||52-Week Range
13.78
-65.31%
Year-to-Date
No recent news for CymaBay Therapeutics Inc.

Today’s Trading

Previous close3.50
Today’s open3.50
Day’s range3.41 - 3.71
Volume55,490
Average volume (3 months)121,157
Market cap$52.0M
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+25.14%
Earnings growth (this year)+42.01%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
DITAMCON Distributing C...0.000.00%
NRXNephroGenex Inc-0.04-0.61%
MCPIEMed Cannabis Pharma ...0.000.00%
BIOSBioScrip Inc-0.10-2.74%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$0.00
Annual profit (last year)-$31.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Harold E. van Wart
CFO, Secretary &
Head-Investor Relations
Sujal Shah
Corporate headquarters
Newark, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers